ScholarLens Back to search
2008•Unpublished venueRequires access

Pravastatin Clinical Observation of Hyperlipidemia

Xuelin Li

Open publisher page 0 citations

Abstract

Objective:Purpose of pravastatin treatment of patients with hyperlipidemia analysis.Methods:108 cases confirmed dyslipidemia is atherosclerosis in patients with pravastatin(Pula solid):Capsules 10 mg,once daily.Bedtime taking it for 12 months.Results:Pravastatin treatment of patients with hyperlipidemia high fat benefit not only from its lipid-lowering effect,but also from the drug in a stable plaque,improve inflammation,reduce platelet aggregation,and other aspects of lipid-lowering effect.Clinical see the control group(P0.05).Conclusion:Pravastatin treatment of hyperlipidemia patients to be effective.

About this research paper

What this paper is about

Objective:Purpose of pravastatin treatment of patients with hyperlipidemia analysis.Methods:108 cases confirmed dyslipidemia is atherosclerosis in patients with pravastatin(Pula solid):Capsules 10 mg,once daily.Bedtime taking it for 12 months.Results:Pravastatin treatment of patients with hyperlipidemia high fat benefit not only from its lipid-lowering effect,but also from the drug in a stable plaque,improve inflammation,reduce platelet aggregation,and other aspects of lipid-lowering effect.Clinical see the control group(P0.05).Conclusion:Pravastatin treatment of hyperlipidemia patients to be effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:Purpose of pravastatin treatment of patients with hyperlipidemia analysis.Methods:108 cases confirmed dyslipidemia is atherosclerosis in patients with pravastatin(Pula solid):Capsules 10 mg,once daily.Bedtime taking it for 12 months.Results:Pravastatin treatment of patients with hyperlipidemia high fat benefit not only from its lipid-lowering effect,but also from the drug in a stable plaque,improve inflammation,reduce platelet aggregation,and other aspects of lipid-lowering effect.Clinical see the control group(P0.05).Conclusion:Pravastatin treatment of hyperlipidemia patients to be effective.

Key concepts: Pravastatin, Medicine, Hyperlipidemia, Dyslipidemia, Bedtime, Internal medicine, Pharmacology, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Pravastatin Clinical Observation of Hyperlipidemia — Research Paper | ScholarLens